Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2004-7-22
pubmed:abstractText
Imatinib mesylate (Gleevec), an inhibitor of the BCR-ABL tyrosine kinase, was introduced recently into the therapy of chronic myeloid leukemia (CML). Several cases of emergence of clonal chromosomal abnormalities after therapy with imatinib have been reported, but their incidence, etiology and prognosis remain to be clarified. We report here a large series of 34 CML patients treated with imatinib who developed Philadelphia (Ph)-negative clones. Among 1001 patients with Ph-positive CML treated with imatinib, 34 (3.4%) developed clonal chromosomal abnormalities in Ph-negative cells. Three patients were treated with imatinib up-front. The most common cytogenetic abnormalities were trisomy 8 and monosomy 7 in twelve and seven patients, respectively. In 15 patients, fluorescent in situ hybridization with specific probes was performed in materials archived before the initiation of imatinib. The Ph-negative clone was related to previous therapy in three patients, and represented a minor pre-existing clone that expanded after the eradication of Ph-positive cells with imatinib in two others. However, in 11 patients, the new clonal chromosomal abnormalities were not detected and imatinib may have had a direct effect. No myelodysplasia was found in our cohort. With a median follow-up of 24 months, one patient showed CML acceleration and two relapsed.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0887-6924
pubmed:author
pubmed-author:AwdehM RMR, pubmed-author:BastieJ NJN, pubmed-author:CastaigneSS, pubmed-author:CharrinCC, pubmed-author:DastugueNN, pubmed-author:EclacheVV, pubmed-author:FlandrinGG, pubmed-author:France Intergroupe pour la Leucemie Myeloide Chronique, pubmed-author:GervaisCC, pubmed-author:GiraudierSS, pubmed-author:ImbertMM, pubmed-author:Lafage-PochitaloffMM, pubmed-author:LaurentGG, pubmed-author:LeonardCC, pubmed-author:LessardMM, pubmed-author:LeymarieVV, pubmed-author:MaarekOO, pubmed-author:MaloiselFF, pubmed-author:MossafaHH, pubmed-author:MozziconacciM JMJ, pubmed-author:MugneretFF, pubmed-author:N'Guyen KhacFF, pubmed-author:NicoliniFF, pubmed-author:RedmanC LCL, pubmed-author:RousselotPP, pubmed-author:RoussiJJ, pubmed-author:RouxG LGL, pubmed-author:SallesBB, pubmed-author:TalmantPP, pubmed-author:TerreCC, pubmed-author:Van den AkkerJJ, pubmed-author:VernantJ PJP, pubmed-author:VeyNN, pubmed-author:VigierMM, pubmed-author:ViguiéFF, pubmed-author:YacoubenYY
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1340-6
pubmed:dateRevised
2007-11-21
pubmed:meshHeading
pubmed-meshheading:15190256-Adult, pubmed-meshheading:15190256-Aged, pubmed-meshheading:15190256-Aneuploidy, pubmed-meshheading:15190256-Chromosome Aberrations, pubmed-meshheading:15190256-Chromosomes, Human, Pair 7, pubmed-meshheading:15190256-Chromosomes, Human, Pair 8, pubmed-meshheading:15190256-Clone Cells, pubmed-meshheading:15190256-Female, pubmed-meshheading:15190256-Humans, pubmed-meshheading:15190256-Incidence, pubmed-meshheading:15190256-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:15190256-Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, pubmed-meshheading:15190256-Male, pubmed-meshheading:15190256-Middle Aged, pubmed-meshheading:15190256-Piperazines, pubmed-meshheading:15190256-Prognosis, pubmed-meshheading:15190256-Pyrimidines, pubmed-meshheading:15190256-Retrospective Studies
pubmed:year
2004
pubmed:articleTitle
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
pubmed:affiliation
Cytogenetic and Clinical Departments, Hôpital André Mignot, Versailles, France. cterre@ch-versailles.fr
pubmed:publicationType
Journal Article, Multicenter Study